Stroke code simulation benefits advanced practice providers similar to neurology residents

Autor: Michelle De Jesus, Adam Oostema, Robert R. Coleman, Joseph Zachariah, Tamer Abdelhak, Cynthia Hingtgen, Tricia Tubergen, Theresa Price, Omran Kaskar, Wendy Sherman, Muhib Khan, Brien J. Smith, Brian Silver, Grayson L. Baird, Raymond Scurek

Publikováno v: Neurology: Clinical Practice. 8:116-119

BackgroundAdvanced practice providers (APPs) are important members of stroke teams. Stroke code simulations offer valuable experience in the evaluation and treatment of stroke patients without compromising patient care. We hypothesized that simulatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8a778913010dd4acbf896a4bf12223f
https://doi.org/10.1212/cpj.0000000000000435

Pregnancy in a Series of Dystonia Patients Treated with Deep Brain Stimulation: Outcomes and Management Recommendations

Autor: Robert R. Coleman, Harrison C. Walker, Philip A. Starr, Monica Volz, Stephanie Guthrie, Jill L. Ostrem, William J. Marks, Nathan Ziman

Publikováno v: Ziman, N; Coleman, RR; Starr, PA; Volz, M; Jr, MWJ; Walker, HC; et al.(2016). Pregnancy in a Series of Dystonia Patients Treated with Deep Brain Stimulation: Outcomes and Management Recommendations. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 94(1), 60-65. doi: 10.1159/000444266. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/3wg2x2s5
Stereotactic and functional neurosurgery, vol 94, iss 1

Background: Medically refractory dystonia affects children and young adults, and deep brain stimulation (DBS) can allow some patients to regain functional independence. Women with dystonia treated with DBS may wish to conceive a child, but there is l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15715eb46b3329abdfd20053ed226dd8
http://www.escholarship.org/uc/item/3wg2x2s5

Patient selection

Autor: Robert R. Coleman, Jill L. Ostrem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::95ce7902f60a26973635e7aed2710c17
https://doi.org/10.1017/cbo9781316026625.003

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).

Autor: Auranen A; Tays Cancer Centre and FICAN Mid, Tampere University and Tampere University Hospital, Pirkanmaa Hospital District, FM3 2.krs. Biokatu 10, Tampere 33900, Finland., Powell MA; National Cancer Institute Sponsored NRG Oncology, Washington University School of Medicine, St Louis, MO, USA., Sukhin V; Grigoriev Institute for Medical Radiology and Oncology National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine., Landrum LM; Indiana University Health and Simon Cancer Center, Indianapolis, IN, USA., Ronzino G; Department of Oncology, Ospedale 'Vito Fazzi,' Lecce, Italy., Buscema J; Gynecologic Oncology, Arizona Oncology, Tucson, AZ, USA., Bauerschlag D; University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Lalisang R; Department of Internal Medicine, Maastricht UMC Comprehensive Cancer Center, GROW-School of Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands., Bender D; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA, USA., Gilbert L; Division of Gynecologic Oncology, Gerald Bronfman Department of Oncology, Research Institute-McGill University Health Centre, McGill University, Montreal, QC, Canada., Armstrong A; Division of Gynecologic Oncology, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, OH, USA., Safra T; Department of Oncology, Tel Aviv Sourasky Medical Center, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Nevadunsky N; Department of Obstetrics, Gynecology, and Women's Health, Montefiore Medical Center, Bronx, NY, USA., Sebastianelli A; CHU de Québec-Université Laval, Québec, QC, Canada., Slomovitz B; Department of Gynecologic Oncology, Mount Sinai Medical Center, and Department of Obstetrics and Gynecology, Florida International University, Miami Beach, FL, USA., Ring K; University of Virginia Health System, Charlottesville, VA, USA., Coleman R; Texas Oncology, US Oncology Network, The Woodlands, TX, USA., Podzielinski I; Department of Gynecologic Oncology, Parkview Health, Fort Wayne, IN, USA., Stuckey A; Women and Infants Hospital of Rhode Island, Providence, RI, USA., Teneriello M; US Oncology Research, The Woodlands, TX, USA., Gill S; St. Joseph's/Candler Gynecologic Oncology and Surgical Specialists, Candler Hospital, Savannah, GA, USA., Pothuri B; GOG Foundation and Departments of Obstetrics/Gynecology and Medicine, Division of Gynecologic Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Willmott L; Arizona Oncology, Phoenix, AZ, USA., Sharma S; Department of Obstetrics/Gynecology, AMITA Health Adventist Medical Center, Hinsdale, IL, USA., Dabrowski C; GSK, Collegeville, PA, USA., Antony G; GSK, London, UK., Stevens S; GSK, London, UK., Mirza MR; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Nordic Society of Gynaecologic Oncology Clinical Trial Unit, Copenhagen, Denmark., Fleming E; Division of Gynecologic Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Sep 28; Vol. 16, pp. 17588359241277656. Date of Electronic Publication: 2024 Sep 28 (Print Publication: 2024).